AMRZ Market Analysis

Overview

Fundamentals

P/E ratio26.30Forward 18.45
EPS (TTM)$2.033.6% YoY
Profit margin9.7%BASIC MATERIALS
Market cap$29.54BLarge cap

Wall Street coverage

$65.34median target· current $51.99 (+25.7%)20 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
18.45
PEG ratio
1.42
P/B
2.26
P/S (TTM)
2.48
EV/EBITDA
12.82

Profitability & growth

ROE (TTM)
10.1%
Operating margin
-3.7%
Revenue growth YoY
4.7%
Dividend yield
0.8%
Beta
Last earnings
Feb 17, 2026 · Estimate $0.62 · Reported $0.62
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Amrize Ltd

Amrize Ltd (AMRZ) is a cutting-edge technology firm revolutionizing the digital health and wellness sector by leveraging advanced technologies and data-driven solutions to enhance healthcare delivery. Focused on improving patient outcomes and expanding healthcare accessibility, Amrize is committed to extensive research and development that caters to the escalating demand for scalable health innovations. Its strategic initiatives and robust product offerings position the company as a significant contributor to the transformation of modern healthcare systems, making it a compelling investment…

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
GRAFENAUWEG 8, ZUG, SWITZERLAND
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$29.54B
Shares outstanding$553.5M
52W high$65.43
52W low$43.78

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer